CompletedNCT03855631
Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders
Studying Kabuki syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Montpellier
- Principal Investigator
- Alessio Zippo, PhDCenter of Integrative Biology
- Intervention
- Intervention on primary cultured cells(genetic)
- Enrollment
- 8 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2020 – 2020
Study locations (1)
- Arnaud de villeneuve Hospital, Montpellier, Herault, France
Collaborators
Association Française contre les Myopathies Telethon
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03855631 on ClinicalTrials.gov